Related Experiment Video

Updated: Aug 16, 2026

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
09:46

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells

Published on: December 27, 2017

Bleeding signs in children with idiopathic thrombocytopenic purpura

George R Buchanan1

  • 1Division of Hematology-Oncology, Department of Pediatrics, 5323 Harry Hines Boulevard, Dallas, TX 75390-9063, USA. george.buchanan@utsouthwestern.edu

Journal of Pediatric Hematology/Oncology
|December 12, 2003
PubMed

Insights

Clinical bleeding signs, not platelet counts, should guide treatment for children with idiopathic thrombocytopenic purpura (ITP). Future research must focus on bleeding severity and patient quality of life.

Area of Science:

  • Pediatrics
  • Hematology
  • Immunology

Background:

  • Idiopathic thrombocytopenic purpura (ITP) is a bleeding disorder.
  • Current ITP management often overemphasizes platelet counts.
  • Bleeding signs in pediatric ITP are frequently overlooked in research.

Purpose of the Study:

  • To advocate for prioritizing bleeding signs in pediatric ITP management.
  • To highlight the inadequacy of focusing solely on platelet counts.
  • To guide future research in childhood ITP.

Main Methods:

  • Review of existing literature on idiopathic thrombocytopenic purpura (ITP) clinical trials and case series.
  • Analysis of the reporting of bleeding signs in ITP studies.
  • Identification of key outcome measures for future ITP research.

Main Results:

  • Bleeding signs are underreported in ITP literature, except for intracranial bleeding.
  • Platelet counts are often the primary outcome, overshadowing clinical bleeding.
  • A significant gap exists in research addressing bleeding manifestations.

Conclusions:

  • Management of childhood ITP should prioritize clinical bleeding assessment over platelet counts.
  • Future ITP studies must comprehensively evaluate bleeding signs, quality of life, and treatment toxicity.
  • A shift in research focus is needed for better pediatric ITP outcomes.

More Related Videos

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry04:32

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry

Published on: June 5, 2019

Microfluidics in Assessing Platelet Function06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Related Concept Videos

Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...